BioLineRx ADS Representing 15
Stock
Stock
ISIN: US09071M2052
Ticker: BLRX
US09071M2052
BLRX
Price
Price
CHART BY
Frequently asked questions
What is BioLineRx ADS Representing 15's market capitalization?
The market capitalization of BioLineRx ADS Representing 15 is $19.97M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for BioLineRx ADS Representing 15?
BioLineRx ADS Representing 15's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.268. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for BioLineRx ADS Representing 15's stock?
Currently, 2 analysts cover BioLineRx ADS Representing 15's stock, with a consensus target price of $4.567. Analyst ratings provide insights into the stock's expected performance.
What is BioLineRx ADS Representing 15's revenue over the trailing twelve months?
Over the trailing twelve months, BioLineRx ADS Representing 15 reported a revenue of $21.99M.
What is the EBITDA for BioLineRx ADS Representing 15?
BioLineRx ADS Representing 15's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$24.93M. EBITDA measures the company's overall financial performance.
What is the free cash flow of BioLineRx ADS Representing 15?
BioLineRx ADS Representing 15 has a free cash flow of -$30.35M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does BioLineRx ADS Representing 15 have, and what sector and industry does it belong to?
BioLineRx ADS Representing 15 employs approximately 38 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.
What is the free float of BioLineRx ADS Representing 15's shares?
The free float of BioLineRx ADS Representing 15 is 88.62M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $19.97M
- EPS (TTM)
- -$0.268
- Free Float
- 88.62M
- Revenue (TTM)
- $21.99M
- EBITDA (TTM)
- -$24.93M
- Free Cashflow (TTM)
- -$30.35M
Pricing
- 1D span
- $0.209$0.244
- 52W span
- $0.19$1.59
Analyst Ratings
The price target is $4.567 and the stock is covered by 2 analysts.
Buy
2
Hold
0
Sell
0
Information
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.
- Employees
- 38
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- US09071M2052
- Primary Ticker
- BLRX